- Presentations
- 2
- Markets
- 1
Dificid is a brand of Fidaxomicin marketed by Merck Sharp & Dohme, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Fidaxomicin
- Brand owner
- Merck Sharp & Dohme
- Registered in
- United States
- Strengths and forms
- 200 mg/5 mL oral suspension, 200 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Dificid 200 mg/5 mL oral suspensionOral | Merck Sharp & Dohme | US FDA | Available on request |
| Dificid 200 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Dificid
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.